findmyKOL
Clinical trialNCT03970447RecruitingPhase 2/PHASE3Interventional

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

SponsorGlobal Coalition for Adaptive ResearchEnrollment2,250Glioblastoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

63 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Northern Sydney Cancer Centre/royal North Shore Hospital

    St Leonards, New South Wales, Australia

    Helen Wheeler, MD
    Recruiting
  • Calvary Mater Newcastle

    Waratah, New South Wales, Australia

    Faisal Hayat, MD
    Recruiting
  • Royal Brisbane and Women'S Hospital

    Herston, Queensland, Australia

    Zarnie Lwin, MD
    Recruiting
  • Flinders Medical Centre

    Bedford Park, South Australia, Australia

    Ganessan Kichenadasse, MD
    Recruiting
  • Austin Health

    Heidelberg, Victoria, Australia

    Hui Gan, MBBS, FRACP, PhD
    Recruiting
  • Peter Maccallum Cancer Centre

    Melbourne, Victoria, Australia

    Jim Whittle, MD
    Recruiting
Canada
  • Princess Margaret Cancer Centre

    Toronto, Ontario, Canada

    Warren Mason, MD
    Recruiting
  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada

    James Perry, MD, FRCPC
    Recruiting
  • Montreal Neurological Institute and Hospital, Mcgill University

    Montreal, Quebec, Canada

    Scott Owen, MD
    Recruiting
  • Université de Sherbrooke

    Sherbrooke, Quebec, Canada

    Active, not recruiting
France
  • Centre Hospitalier Lyon Sud / Hôpital Neurologique P. Wertheimer

    Bron, France

    Francois Ducray, MD
    Recruiting
  • Hopital de la Timone

    Marseille, France

    Emelie Tabouret, MD
    Recruiting
  • Hopital Piti-Salpetriere

    Paris, France

    Mehdi Touat, MD
    Recruiting
Germany
  • Uniklinik Koeln - Zentrum Fuer Neurologie Und Psychiatrie

    Cologne, Germany

    Active, not recruiting
  • Dr. Senckenbergisches Institut Für Neuroonkologie

    Frankfurt, Germany

    Michael Ronellenfitsch, MD, PhD
    Recruiting
  • Universitätsklinik Heidelberg

    Heidelberg, Germany

    Antje Wick, MD
    Recruiting
  • Universitaetsklinikum Heidelberg - Neurologische Klinik

    Mannheim, Germany

    Michael Platten, MD
    Recruiting
  • Universitätsklinikum Regensburg

    Regensburg, Germany

    Peter Hau, MD
    Recruiting
  • Universitätsklinikum Tübingen

    Tübingen, Germany

    Ghazaleh Tabatabai, MD
    Recruiting
Switzerland
  • Centre Hospitalier Universitaire Vaudois Lausanne

    Lausanne, Canton of Vaud, Switzerland

    Andreas Hottinger, MD
    Recruiting
  • University Hospital Zurich

    Zurich, Switzerland

    Michael Weller, MD
    Recruiting
United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

    Louis B Nabors, MD
    Recruiting
  • University of California, San Diego

    La Jolla, California, United States

    David Piccioni, MD, PhD
    Recruiting
  • Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute

    Los Angeles, California, United States

    Jethro Hu, MD
    Recruiting
  • University of California, Los Angeles

    Los Angeles, California, United States

    Phioanh Nghiemphu, MD
    Recruiting
  • St. Joseph Hospital

    Orange, California, United States

    Lars Anker, MD
    Recruiting
  • University of California, San Francisco

    San Francisco, California, United States

    Nicholas Butowski, MD
    Recruiting
  • Stanford Cancer Center

    Stanford, California, United States

    Completed
  • University of Colorado Denver

    Aurora, Colorado, United States

    Denise Damek, MD
    Recruiting
  • Yale Cancer Center / Smilow Cancer Hospital*

    New Haven, Connecticut, United States

    Nicholas Blondin, MD
    Recruiting
  • Mayo Clinic Cancer Center

    Jacksonville, Florida, United States

    Completed
  • Sylvester Comprehensive Cancer Center*

    Miami, Florida, United States

    Macarena I De La Fuente, MD
    Recruiting
  • Moffitt Cancer Center

    Tampa, Florida, United States

    Patrick Grogan, MD
    Recruiting
  • Piedmont Atlanta Hospital

    Atlanta, Georgia, United States

    Erin Dunbar, MD
    Recruiting
  • Winship Cancer Institute of Emory University

    Atlanta, Georgia, United States

    Completed
  • Lsu Health Sciences Center - New Orleans

    New Orleans, Louisiana, United States

    Completed
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Patrick Wen, MD
    Recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Patrick Wen, MD
    Recruiting
  • Henry Ford Health System

    Detroit, Michigan, United States

    Completed
  • Allina Health Systems/abbott Northwestern Hospital

    Minneapolis, Minnesota, United States

    Andrea Wasilewski, MD
    Recruiting
23 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jul 2019
Primary completion
30 Jun 2028
Completion
30 Jun 2030
Last update posted
26 Jun 2026
Registered enrollment
2,250
Registry id
NCT03970447

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.